| Topline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non ... - PR Newswire (press release) |
|
|
PR Newswire (press release)... imatinib mesylate, and advanced/metastatic renal cell carcinoma (RCC) based on efficacy and safety data from large, randomized Phase 3 clinical trials. ... read more |